2018年11月26日 · Emdolten TM, a once a day triple combination tablet therapy in the form of Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate, is positioned to become a preferred first line ARV and will be available in 50mg, 300mg/300mg dosage strengths.

2018年11月30日 · 南非制药商Aspen Pharmacare周一推出了一种三联组合片剂，用于治疗该国最为流行的艾滋病毒。 Aspen说，该公司的新型Emdolten药物是一种每日一次的药片，其中一种成分为dolutegravir，这是一种抗逆转录病毒药物，可抵抗艾滋病毒治疗过程中常见的耐药性。 该药还含有拉米夫定和替诺福韦地索普西富马酸盐以及dolutegravir。 今年5月，南非健康产品监管局和欧洲药品管理局发出警告，建议医生不要给寻求怀孕的妇女开多替拉韦。 这是根据博茨瓦纳一 …

2018年11月27日 · The company's new Emdolten drug is a once-a-day tablet in the form of dolutegravir, an antiretroviral medication that counters the drug resistance that often develops with older HIV treatments...

Tenofovir diphosphate inhibits HIV-1 reverse transcriptase and the HBV polymerase by direct binding competition with the natural deoxyribonucleotide substrate and, after incorporation into DNA, by DNA chain termination. This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

2025年1月1日 · TLD is a generic HIV combination. It contains tenofovir disoproxil, lamivudine and dolutegravir. Sometime the tablet are marked LTD. TLD is a very good combination and is now the most widely used ART. It is recommended by the WHO. This combination is only available in either low or middle-income countries.

2019年12月6日 · Health Minister Zweli Mkhize has launched a new three-in-one pill that could not only help people with HIV take control of their health faster and with fewer side effects but could avert more than...

2018年12月5日 · South African drug-maker Aspen Pharmacare has launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent, reports Reuters Health. The company’s new Emdolten drug is a once-a-day tablet in the form of dolutegravir, an antiretroviral medication that counters the drug resistance that often ...

2018年11月26日 · Emdolten ®, a once a day triple combination tablet therapy in the form of Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate, is positioned to become a preferred first line ARV and will be available in 50mg, 300mg/300mg dosage strengths.

2018年11月28日 · Emdolten, a once a day triple combination tablet therapy in the form of Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate, is positioned to become a preferred first line ARV and will be available in 50mg, 300mg/300mg dosage strengths.

3000580 Emdolten Tablet Antiviral Combinations - Dolutegravir, tenofovir disoproxil and lamivudine 265 3000426 Acriptega Tablet ... 721595 Norvir 100mg Tablet Antivirals - Protease Inhibitors 45 . Discovery Health Medical Scheme, registration number 1125, is regulated by the Council for Medical Schemes and administered by Discovery Health (Pty ...